Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Annals of General Psychiatry|January 27, 2009
An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorderQin Jiang, Saeeduddin AhmedCNS Spectrums|September 7, 2007
Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ERStephen M Stahl, Saeeduddin Ahmed, Vincent HaudiquetThe American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Biomarkers in psychotropic drug developmentSaeeduddin Ahmed, P David Mozley, William Z PotterPrimary Care Companion to the Journal of Clinical Psychiatry|September 14, 2004
The Metabolic Syndrome in Patients With Severe Mental IllnessesPatrick Toalson, Saeeduddin Ahmed, Thomas Hardy, et al.Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Mood Disorders in Family Practice: Beyond Unipolarity to BipolarityJ Sloan Manning, Saeeduddin Ahmed, Hillary C. McGuire, et al.Annals of the New York Academy of Sciences|January 29, 2005
Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month studyBruce J Kinon, Hong Liu-Seifert, Jonna Ahl, et al.The International Journal of Neuropsychopharmacology|June 12, 2008
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysisDan J Stein, Ron Pedersen, Barbara O Rothbaum, et al.Schizophrenia Research|April 22, 2004
An excitement subscale of the Positive and Negative Syndrome ScaleJean-Pierre Lindenmayer, Eileen Brown, Robert W Baker, et al.Journal of Clinical Psychopharmacology|January 15, 2009
Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizersSheldon Preskorn, Albena Patroneva, Heather Silman, et al.Journal of Clinical Pharmacology|November 13, 2008
The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adultsAlice I Nichols, Penny Fatato, Magdy Shenouda, et al.Pageof 2